EcoDrugPlus

Proteasome 26s Subunit, Non-Atpase 8

Ensembl ID : ENSLACG00000015516
Gene Symbol: PSMD8
4 Cross references
211 Possible Orthologues:

Proteasome Subunit Beta Type-11-Like

Ensembl ID : ENSLACG00000015163
Gene Symbol: LOC102358862
3 Cross references
226 Possible Orthologues:

Proteasome Subunit Beta Type-5 Pseudogene

Ensembl ID : ENSLACG00000004162
Gene Symbol: LOC102365115
1 Cross references
222 Possible Orthologues:

Protein Arginine Methyltransferase 5

Ensembl ID : ENSLACG00000011043
Gene Symbol: PRMT5
3 Cross references
198 Possible Orthologues:

Protein Kinase C Alpha

Ensembl ID : ENSLACG00000004445
Gene Symbol: PRKCA
4 Cross references
289 Possible Orthologues:

Protein Kinase C Beta

Ensembl ID : ENSLACG00000002827
Gene Symbol: PRKCB
3 Cross references
287 Possible Orthologues:

Protein Kinase C Delta

Ensembl ID : ENSLACG00000013307
Gene Symbol: PRKCD
4 Cross references
280 Possible Orthologues:

Protein Kinase C Epsilon

Ensembl ID : ENSLACG00000005560
Gene Symbol: PRKCE
3 Cross references
293 Possible Orthologues:

Protein Kinase C Eta

Ensembl ID : ENSLACG00000018333
Gene Symbol: PRKCH
3 Cross references
239 Possible Orthologues:

Protein Kinase C Gamma

Ensembl ID : ENSLACG00000007559
Gene Symbol: PRKCG
4 Cross references
199 Possible Orthologues:

Protein Kinase C Iota

Ensembl ID : ENSLACG00000014835
Gene Symbol: PRKCI
3 Cross references
14 Possible Orthologues:

Protein Kinase C Theta

Ensembl ID : ENSLACG00000016489
Gene Symbol: PRKCQ
3 Cross references
204 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).